ADO 3.85% 2.7¢ anteotech ltd

Ann: Distribution Agreement with Major China Distribution Company, page-75

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 271 Posts.
    lightbulb Created with Sketch. 58
    See for an old guy you have learnt nothing as exemplified by your posts.

    Ignore the pumping of the day traders. They come and go....we all know who they are and we simply ignore them and always will. Don't mix the regulars with the day traders!


    Nobody is backslapping here....the stock is at 2c but has some solid science behind it. If you want to see a stock that is in dire trouble check out Medibio.....from $50 mil cap to $4 mil and a massive capital raise ahead....and No science behind them. Tough lesson for the poor shareholders on that stock because their research, will NOT lead to FDA approvals, so many $ down the drain. There are many others mate.


    ADO have published findings in reputable peer reviewed journals, so the science works and works well...we just have to wait until it is transferred to Industry. In 2010 I spent serious time with Astra Zenica in Aldery Edge in Manchester, Ireland and Sweden. The time it takes to transfer science into industry is at least 7 years. Most of us here who have been here a while understand that these things will take time. The question is do you?


    Seriously Rameez....you are better than this!

 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $54.77M
Open High Low Value Volume
2.7¢ 2.7¢ 2.7¢ $10.64K 394.2K

Buyers (Bids)

No. Vol. Price($)
11 728771 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 73191 2
View Market Depth
Last trade - 11.00am 07/11/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.